InvestLog
TAOX TAO Synergies Inc. logo

TAOX TAO Synergies Inc.

Healthcare
$4.53-4.03%ClosedMarket Cap: $14.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

1.30

P/S

21.64

EV/EBITDA

-1.23

DCF Value

$2.55

FCF Yield

-40.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

99.9%

Operating Margin

-1430.8%

Net Margin

-3615.4%

ROE

-120.3%

ROA

-80.1%

ROIC

-32.9%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$388.8K$4.3M$—
Q4 null$91.7K$-7.7M$—
FY null$299.1K$-28.7M$—
Q3 null$203.4K$-3.9M$—

Trading Activity

Insider Trades

View All
WEINSTEIN ROBERTofficer: Chief Financial Officer
SellTue May 19
Singer William S.director
SellTue May 19
Silverman Joshuadirector, officer: Executive Chairman
SellTue May 19
Ephron Robertdirector
SellTue May 19
Bernstein Brucedirector
SellTue May 19

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

—

Beta

1.54

Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.

Peers

BOLD logoBOLDCVKD logoCVKDIBIO logoIBIOINTS logoINTSITRM logoITRMKLTO logoKLTONXTC logoNXTCPSTV logoPSTVRLYB logoRLYBSONN logoSONN